No abstract available
MeSH terms
-
Administration, Topical
-
Aminoquinolines / adverse effects
-
Aminoquinolines / therapeutic use*
-
Anti-HIV Agents / therapeutic use
-
Carcinoma in Situ / complications
-
Carcinoma in Situ / drug therapy*
-
Carcinoma in Situ / pathology
-
Cell Transformation, Neoplastic / pathology*
-
Condylomata Acuminata / complications
-
Condylomata Acuminata / drug therapy
-
Condylomata Acuminata / pathology
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Follow-Up Studies
-
HIV Infections / diagnosis*
-
HIV Infections / drug therapy
-
Humans
-
Imiquimod
-
Immunohistochemistry
-
Male
-
Neoplasm Staging
-
Penile Diseases / complications
-
Penile Diseases / drug therapy
-
Penile Diseases / pathology
-
Penile Neoplasms / complications
-
Penile Neoplasms / drug therapy*
-
Penile Neoplasms / pathology
-
Risk Assessment
-
Time Factors
-
Treatment Outcome
Substances
-
Aminoquinolines
-
Anti-HIV Agents
-
Imiquimod